Detalhe da pesquisa
1.
A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
Nephrol Dial Transplant
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520170
2.
Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies.
Diabetes Obes Metab
; 25(2): 501-515, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239122
3.
Sodium-glucose cotransporter-2 inhibitors and kidney outcomes in real-world type 2 diabetes populations: A systematic review and meta-analysis of observational studies.
Diabetes Obes Metab
; 25(8): 2310-2330, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202870
4.
Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis.
Cardiovasc Diabetol
; 20(1): 130, 2021 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34183018
5.
Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism.
Diabet Med
; 38(5): e14452, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33165941
6.
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study.
EClinicalMedicine
; 68: 102426, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38304744
7.
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.
Mol Genet Metab
; 107(3): 534-41, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22959828
8.
All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK.
Diabetes Ther
; 12(5): 1299-1311, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721211
9.
Dashboards to reduce inappropriate prescribing of metformin and aspirin: A quality assurance programme in a primary care sentinel network.
Prim Care Diabetes
; 15(6): 1075-1079, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147402
10.
Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort Study.
Hypertension
; 77(3): 846-855, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33325240
11.
The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease.
J Neurol Neurosurg Psychiatry
; 81(9): 954-7, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20547622
12.
The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.
Diabetes Res Clin Pract
; 164: 108217, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32451317
13.
The effect of WNT5B IVS3C>G on the susceptibility to type 2 diabetes in UK Caucasian subjects.
Nutr Metab Cardiovasc Dis
; 19(2): 140-5, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18555673
14.
Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study.
Eur Heart J
; 29(18): 2244-51, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18573867
15.
How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol.
Diabetes Ther
; 10(3): 1163-1170, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31041781
16.
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study.
Lancet Diabetes Endocrinol
; 6(4): 310-318, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496472
17.
Hypoglycemia, diabetes therapies and driving categories in type 2 diabetes.
Curr Med Res Opin
; 32(6): 1005-12, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26986544
18.
Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes.
BMJ Open Diabetes Res Care
; 4(1): e000192, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158518
19.
Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency.
Biochim Biophys Acta
; 1689(1): 47-57, 2004 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-15158913
20.
Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes.
Br J Gen Pract
; 58(553): 531-3, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18682016